|
|
Article: Intravenous vitamin C is selectively toxic to cancer cells.
- Article from:
- Townsend Letter for Doctors and Patients
- Article date:
- December 1, 2005
CopyrightCOPYRIGHT 2005 The Townsend Letter Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
National Institutes of Health scientists have confirmed the concepts that vitamin C is selectively toxic to cancer cells and that tumor-toxic levels of vitamin C can be attained using intravenous administration. The article, published in the September 12, 2005 issue of the Proceedings of the National Academy of Sciences (1) concluded, "These findings give plausibility to intravenous ascorbic acid in cancer treatment."
Orthomolecular medical researchers, including Nobel laureate Linus Pauling, have long recognized the great importance of vitamin C in fighting cancer. (2) Scientists associated with the Bio-Communications Research Institute (BCRI) in Wichita, Kansas ...